Global Cord BloodCORBF
13F holders, Q1 2025 (March 31)2holders
0new positions
0sold out
$0.90avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding Global Cord Blood Corp. (CORBF) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($22K) and Luminist Capital LLC ($157).
- Company
- Global Cord Blood Corp.
- CUSIP
- G39342103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 19,940 shares sold, net −19,940 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Rhumbline Advisers | 0.00% | Reduce -44.5% | 24,817 | $22K |
| Luminist Capital LLC | 0.00% | No change | 165 | $157 |
"% of holder's portfolio" is CORBF's weight in each manager's 13F, not the share of Global Cord Blood Corp. the manager owns.